NATURE OF INDUSTRY/ACTIVITY: CANCER RESEARCH AND DRUGS
ISIN NO:
INE575G01010
PAID UP EQUITY CAPITAL: FY : 2016-17 Rs. 17.02 cr
FACE VALUE: Rs 1/share
PROMOTERS:
PROMOTERS SHARE HOLDING: Fresenius Kabi (Singapore) Pte Ltd. -97%
BOOK VALUE:
Rs. 25.75 Per share
RESERVES & SURPLUS: Rs. 421.32 cr
REVENUE FROM OPERATION:
Rs. 634.67 cr
PROFIT BEFORE TAX: Rs. 2.14cr
PROFIT AFTER TAX : ( Rs. 2.41cr )
EPS (diluted) : ( Rs. 0. 14 )
DIVIDEND: NIL
COMPANY WEBSITE:
http://www.fresenius-kabi-oncology.com/
COMPANY BROCHURE:
http://www.fresenius-kabi-oncology.com/Annual-Report-for-the-FY-2016-17.pdf
UPDATED AS ON 17.02.2018